UniProt ID | TLR2_HUMAN | |
---|---|---|
UniProt AC | O60603 | |
Protein Name | Toll-like receptor 2 | |
Gene Name | TLR2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 784 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein . Cytoplasmic vesicle, phagosome membrane Single-pass type I membrane protein . Membrane raft . Does not reside in lipid rafts before stimulation but accumulates increasingly in the raft upon the prese |
|
Protein Description | Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. [PubMed: 21078852] | |
Protein Sequence | MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
16 | Phosphorylation | WVLGVIISLSKEESS HHHHHHHHCCCHHCC | 18.57 | 24719451 | |
45 | Phosphorylation | GSSGSLNSIPSGLTE CCCCCCCCCCCCHHH | 40.96 | - | |
48 | Phosphorylation | GSLNSIPSGLTEAVK CCCCCCCCCHHHHHH | 44.77 | - | |
114 | N-linked_Glycosylation | LSYNYLSNLSSSWFK CCHHHHHCCCCCCCC | 41.15 | 15173186 | |
138 | Phosphorylation | LLGNPYKTLGETSLF HCCCCCCCCCCCCHH | 33.87 | - | |
142 | Phosphorylation | PYKTLGETSLFSHLT CCCCCCCCCHHHHHH | 29.00 | - | |
143 | Phosphorylation | YKTLGETSLFSHLTK CCCCCCCCHHHHHHH | 24.10 | 27732954 | |
146 | Phosphorylation | LGETSLFSHLTKLQI CCCCCHHHHHHHHHE | 23.92 | 27732954 | |
149 | Phosphorylation | TSLFSHLTKLQILRV CCHHHHHHHHHEEEE | 25.04 | 27732954 | |
193 | Phosphorylation | LQSYEPKSLKSIQNV HHHCCCCCHHHHHHH | 52.31 | 24719451 | |
196 | Phosphorylation | YEPKSLKSIQNVSHL CCCCCHHHHHHHHHH | 34.40 | 24719451 | |
199 | N-linked_Glycosylation | KSLKSIQNVSHLILH CCHHHHHHHHHHHHH | 35.27 | 15173186 | |
249 | Phosphorylation | LSTGETNSLIKKFTF CCCCCCCCHHHHHHC | 38.60 | 24719451 | |
262 | Phosphorylation | TFRNVKITDESLFQV HCCCCCCCCHHHHHH | 28.17 | - | |
323 | Phosphorylation | RLHIPRFYLFYDLST ECCCCEEEEEEEHHH | 9.36 | - | |
346 | Phosphorylation | KRITVENSKVFLVPC HHCEECCCEEEHHHH | 19.38 | 22210691 | |
401 | Phosphorylation | LRQNHLASLEKTGET HHHCCHHHHHHHCCE | 43.34 | 29396449 | |
405 | Phosphorylation | HLASLEKTGETLLTL CHHHHHHHCCEEEEE | 30.76 | 29396449 | |
408 | Phosphorylation | SLEKTGETLLTLKNL HHHHHCCEEEEECCC | 28.54 | 29396449 | |
411 | Phosphorylation | KTGETLLTLKNLTNI HHCCEEEEECCCCCC | 38.51 | 29396449 | |
414 | N-linked_Glycosylation | ETLLTLKNLTNIDIS CEEEEECCCCCCCCC | 56.03 | 17889651 | |
440 | Phosphorylation | QWPEKMKYLNLSSTR CCCCHHCEECCCCCE | 9.42 | 26074081 | |
442 | N-linked_Glycosylation | PEKMKYLNLSSTRIH CCHHCEECCCCCEEE | 34.48 | 15173186 | |
444 | Phosphorylation | KMKYLNLSSTRIHSV HHCEECCCCCEEEEE | 28.70 | 26074081 | |
445 | Phosphorylation | MKYLNLSSTRIHSVT HCEECCCCCEEEEEC | 25.52 | 26074081 | |
446 | Phosphorylation | KYLNLSSTRIHSVTG CEECCCCCEEEEECC | 30.21 | 26074081 | |
450 | Phosphorylation | LSSTRIHSVTGCIPK CCCCEEEEECCCCCC | 21.00 | 26074081 | |
452 | Phosphorylation | STRIHSVTGCIPKTL CCEEEEECCCCCCCE | 29.38 | 26074081 | |
609 | S-palmitoylation | ILLTGVLCHRFHGLW HHHHHHHHHHHHHHH | 1.69 | 25371237 | |
653 | Phosphorylation | SYSERDAYWVENLMV CHHHHHHHHHHHHHH | 17.80 | - | |
754 | Ubiquitination | QRFCKLRKIMNTKTY HHHHHHHHHHCCCCC | 57.66 | PubMed | |
758 | Phosphorylation | KLRKIMNTKTYLEWP HHHHHHCCCCCEECC | 13.84 | 29759185 | |
761 | Phosphorylation | KIMNTKTYLEWPMDE HHHCCCCCEECCCCH | 12.27 | 29759185 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TLR2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TLR2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LY96_HUMAN | LY96 | physical | 11160242 | |
TOLIP_HUMAN | TOLLIP | physical | 11751856 | |
TLR1_HUMAN | TLR1 | physical | 12077222 | |
TLR2_HUMAN | TLR2 | physical | 10395652 | |
IRAK1_HUMAN | IRAK1 | physical | 10395652 | |
TIRAP_HUMAN | TIRAP | physical | 17258210 | |
TIRAP_HUMAN | TIRAP | physical | 18221795 | |
CLC4M_HUMAN | CLEC4M | physical | 21899704 | |
CLC7A_HUMAN | CLEC7A | physical | 21899704 | |
GAG_HV1H2 | gag | physical | 26347747 | |
STA5A_HUMAN | STAT5A | physical | 28514442 | |
TM214_HUMAN | TMEM214 | physical | 28514442 | |
AVR2A_HUMAN | ACVR2A | physical | 28514442 | |
BMR1A_HUMAN | BMPR1A | physical | 28514442 | |
IPRI_HUMAN | ITPRIP | physical | 28514442 | |
UBP33_HUMAN | USP33 | physical | 28514442 | |
S11IP_HUMAN | STK11IP | physical | 28514442 | |
LGR4_HUMAN | LGR4 | physical | 28514442 | |
AP1M1_HUMAN | AP1M1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00344 | Leprosy; Hansen disease | |||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Crystal structure of the TLR1-TLR2 heterodimer induced by binding ofa tri-acylated lipopeptide."; Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.-G., Lee H.,Lee J.-O.; Cell 130:1071-1082(2007). Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-509 IN COMPLEX WITH TLR1AND BACTERIAL LIPOPEPTIDE ANALOG, DISULFIDE BONDS, AND GLYCOSYLATIONAT ASN-114; ASN-199; ASN-414 AND ASN-442. | |
"Four N-linked glycosylation sites in human toll-like receptor 2cooperate to direct efficient biosynthesis and secretion."; Weber A.N., Morse M.A., Gay N.J.; J. Biol. Chem. 279:34589-34594(2004). Cited for: GLYCOSYLATION AT ASN-114; ASN-199 AND ASN-442, AND MUTAGENESIS OFASN-114; ASN-199; THR-416 AND ASN-442. |